As of 2025-11-03, the EV/EBITDA ratio of NGM Biopharmaceuticals Inc (NGM) is -0.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NGM's latest enterprise value is 72.71 mil USD. NGM's TTM EBITDA according to its financial statements is -149.48 mil USD. Dividing these 2 quantities gives us the above NGM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.3x - 6.1x | 4.7x |
| Forward P/E multiples | 5.6x - 7.3x | 6.4x |
| Fair Price | (9.43) - (10.19) | (9.27) |
| Upside | -712.5% - -761.4% | -702.1% |
| Date | EV/EBITDA |